신속 미생물 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global rapid microbiology testing market size is expected to reach USD 14.97 Billion in 2034 from USD 6.64 Billion in 2025, growing at a CAGR of 9.45 during 2026-2034.This market is growing steadily due to the increasing demand for faster and more accurate microbial testing solutions across healthcare, food, pharmaceutical, and environmental industries. Rapid microbiology testing technologies help detect harmful microorganisms quickly, reducing contamination risks and improving operational efficiency. Rising concerns regarding infectious diseases and product safety are significantly contributing to market expansion globally.

The growing emphasis on quality control and regulatory compliance is a major driver supporting market development. Pharmaceutical manufacturers and food processing companies are increasingly adopting rapid testing methods to ensure product safety and meet stringent industry standards. Technological advancements in molecular diagnostics, automation, and biosensor technologies are also enhancing testing speed, reliability, and overall laboratory productivity.

Future prospects for the market remain highly promising as automation and digital laboratory solutions continue to evolve. Increasing investments in healthcare infrastructure and rising demand for point-of-care diagnostic systems are expected to strengthen industry growth. Expanding applications in environmental monitoring and clinical diagnostics are likely to create substantial opportunities for rapid microbiology testing solution providers in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Consumables
• Instruments
• Reagents & Kits

By Method

• Cellular Component-Based Methods
• Nucleic Acid-Based Methods
• Immunological
• Other Methods

By Application

• Clinical Diagnostics
• Pharmaceutical & Biotech Manufacturing QC
• Food & Beverage Testing
• Other Applications

By End User

• Clinical Laboratories
• Healthcare Facilities (Hospitals & POC)
• Food & Beverage Companies
• Pharma & Biotech Companies
• Other End Users

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc., Becton, Dickinson & Company, Danaher, Merck KGaA, bioMerieux SA, Sartorius AG, Charles River Laboratories, Bruker Corporation, Eurofins Scientific, Bio-Rad Laboratories, QIAGEN N.V., IDEXX Laboratories, Neogen Corporation, Rapid Micro Biosystems, Hygiena LLC

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Cellular Component-Based Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nucleic Acid-Based Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunological Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotech Manufacturing QC Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Food & Beverage Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Healthcare Facilities (Hospitals & POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Food & Beverage Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharma & Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Method
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Method
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Method
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Method
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Method
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL RAPID MICROBIOLOGY TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher ScientificInc
  • 10.2.2 Becton, Dickinson & Company
  • 10.2.3 Danaher
  • 10.2.4 Merck KGaA
  • 10.2.5 BioMerieux SA
  • 10.2.6 Sartorius AG
  • 10.2.7 Charles River Laboratories
  • 10.2.8 Bruker Corporation
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Bio-Rad Laboratories
  • 10.2.11 QIAGEN N.V
  • 10.2.12 IDEXX Laboratories
  • 10.2.13 Neogen Corporation
  • 10.2.14 Rapid Micro Biosystems
  • 10.2.15 Hygiena LLC